Siret D, David V
Clinique médicale pédiatrique, hôpital de la Mère et de l'Enfant, CHU Nantes, 9, Quai-Moncousu, 44093 Nantes, France.
Arch Pediatr. 2002 May;9(5):499-502. doi: 10.1016/s0929-693x(01)00832-6.
Cytomegalovirus infection is common in the immunodepressed child, and because of its severity, is usually treated with intravenous ganciclovir. It is also common in the immunocompetent child, but is usually asymptomatic, so that there is no indication for ganciclovir treatment, because of the potential toxicity of the drug.
We report a case of symptomatic cytomegalovirus infection in a six-week-old infant, presenting with interstitial pneumonia associated with weight and height growth failure. Cytomegalovirus was found by polymerase chain reaction in the bronchovalveolar lavage fluid and in the blood. This child was successfully treated with 15 days of intravenous ganciclovir, and experienced no adverse effect of this treatment. The child was free of symptoms and free of immunodeficiency after seven months of follow-up.
Immunocompetent patients with cytomegalovirus infection, pulmonary involvement and weight and height growth failure, may benefit from intravenous ganciclovir treatment. Further studies, with larger number of cases, are yet needed to define more precisely the indications of such a treatment in the immunocompetent child.
巨细胞病毒感染在免疫抑制儿童中很常见,由于其严重性,通常用静脉注射更昔洛韦治疗。它在免疫功能正常的儿童中也很常见,但通常无症状,因此由于该药物的潜在毒性,没有使用更昔洛韦治疗的指征。
我们报告一例六周大婴儿出现症状性巨细胞病毒感染的病例,表现为间质性肺炎并伴有体重和身高增长迟缓。通过聚合酶链反应在支气管肺泡灌洗液和血液中发现了巨细胞病毒。该患儿接受了15天的静脉注射更昔洛韦治疗,治疗成功,且未出现该治疗的不良反应。经过七个月的随访,患儿无症状且无免疫缺陷。
免疫功能正常但感染巨细胞病毒、有肺部受累及体重和身高增长迟缓的患者,可能从静脉注射更昔洛韦治疗中获益。还需要更多病例的进一步研究,以更精确地确定这种治疗在免疫功能正常儿童中的指征。